MEEDER ASSET MANAGEMENT INC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2020$39,000
-29.1%
13,547
-31.4%
0.00%
-25.0%
Q1 2020$55,000
-11.3%
19,762
+4.6%
0.00%0.0%
Q4 2019$62,000
-28.7%
18,895
-31.7%
0.00%
-33.3%
Q2 2019$87,000
-25.6%
27,671
-12.9%
0.01%
-33.3%
Q1 2019$117,000
-2.5%
31,753
-23.8%
0.01%
-18.2%
Q4 2018$120,000
-20.5%
41,648
-27.4%
0.01%0.0%
Q3 2018$151,000
-99.8%
57,350
+76.9%
0.01%
+57.1%
Q2 2018$75,874,000
+270878.6%
32,425
+229.3%
0.01%
+133.3%
Q1 2018$28,000
+75.0%
9,846
+72.3%
0.00%
+200.0%
Q4 2017$16,000
+33.3%
5,713
+65.0%
0.00%0.0%
Q3 2017$12,000
+33.3%
3,4620.0%0.00%0.0%
Q2 2017$9,000
-96.4%
3,462
-95.7%
0.00%
-95.7%
Q2 2016$251,000
-5.6%
79,8170.0%0.02%
-8.0%
Q1 2016$266,000
-37.7%
79,817
-33.8%
0.02%
-35.9%
Q4 2015$427,000
+1155.9%
120,638
+1674.6%
0.04%
+1200.0%
Q3 2015$34,000
-90.0%
6,798
-84.6%
0.00%
-93.0%
Q4 2014$339,00044,0450.04%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Silver Point Capital L.P. 23,783,273$58,745,0006.82%
Park West Asset Management LLC 14,397,212$35,561,0000.74%
GABELLI & Co INVESTMENT ADVISERS, INC. 633,700$1,565,0000.24%
JBF Capital, Inc. 543,990$1,344,0000.22%
Context Capital Management, LLC 465,172$1,149,0000.16%
Bellecapital International Ltd. 108,025$267,0000.09%
FNY Investment Advisers, LLC 100,000$247,0000.07%
WINTON GROUP Ltd 291,360$720,0000.05%
HANCOCK WHITNEY CORP 187,757$464,0000.02%
Freedom Investment Management, Inc. 54,735$135,0000.02%
View complete list of PDL BIOPHARMA INC shareholders